Healthcare broadly, and digital health specifically, is going through a disruptive phase, both in terms of technology (IOT, Cloud, AI, ML) but also in terms of investment and M&A activity. The number of startups funded and the amount of capital invested have continued to increase every year over the past decade. Not only are we seeing the continued increase in the number of digital health unicorns, but companies such as Amazon, Google and Apple leveraging their reach, capital and technology platforms to disrupt the healthcare industry. Healthcare industry, as we know it, will be leapfrogged and obsolesced in the coming decades.
About Vini JollyPillar of Excellence Leader - Venture Capital for Start-ups - Executive Director Silicon Valley, Woodside Capital - - Vini Jolly is a versatile and experienced business executive with over twenty years of both strategic and operating roles across a variety of industries, from networking and digital health, to pharmaceuticals and genomics. Vini brings deep experience in product strategy, marketing, sales and business development in small and large companies and across a variety of technologies and sectors. Vini’s career started with product management and marketing positions at large technology companies including 3com, com21, and Accenture. She was also part of the cardiovascular sales and marketing team at Pfizer where she exceeded her goals every quarter. More recently Vini served as product manager at Genecloud, a genomic data security startup; and business development lead at Retrofit, an online health and disease management startup. In both cases, Vini was instrumental in determining the product-market fit, as well as onboarding initial strategic sales and distribution partnerships.
January 3, 2020 215
Session Abstract: Prepare for an “Industrial Data Revolution” and explore an evolving world of AI and…